Table 1.
Characteristics of study subjects.
| Patient ID | Sex | Age (years) |
CD4 count (cell/ml) |
Viral load (copies/ml) |
HLA type | HLA-B*57/5801 epitopes | HLA-C epitopes |
|---|---|---|---|---|---|---|---|
| SK 009 | Male | 32 | 291 | 47,000 | A*2301/74 B*1503/5702 Cw*0202/0701 | TSTLQEQIAW (p24) | KRQEILDLWVY(Nef) |
| SK 215 | Female | 35 | 202 | 34,800 | A*6802/74 B*0702/5703 Cw*07/07 | ISPRTLNAW (p24) | KRQEILDLWVY(Nef) |
| SK 236 | Female | 37 | 411 | 9900 | A*02/3002 B*0801/5801 Cw*07/07 | ISPRTLNAW (p24) | KRQEILDLWVY(Nef) |
| SK 251 | Female | 58 | 271 | 2530 | A*02/3001 B*4201/5801 Cw*07/1701 | QATQDVKNW (p24) | KRQEILDLWVY(Nef) |
| SK 318 | Female | 27 | 370 | 3600 | A*33/74B*0702/5703 Cw*07/07 | KAFSPEVIPMF (p24) | KRQEILDLWVY(Nef) |
| SK 358 | Female | 42 | 264 | 750,000 | A*0202/2301 B*08/5701 Cw*07/07 | ISPRTLNAW (p24) | KRQEILDLWVY(Nef) |
| SK 364 | Female | 38 | 305 | 11,500 | A*02/3001 B*4201/5801 Cw*07/1701 | QATQDVKNW (p24) | KRQEILDLWVY(Nef) |
| SK 379 | Male | 44 | 267 | 4310 | A*0205/0208 B*0702/5801 Cw*07/07 | TSTLQEQIAW (p24) | KRQEILDLWVY(Nef) |
| SK 428 | Female | 45 | 214 | 272,000 | A*0205/0208 B*1401/5801 Cw*07/08 | TSTLQEQIAW (p24) | KRQEILDLWVY(Nef) |
| Median | 38 | 271 | 11,500 |